Disease-modifying antirheumatic drug - PDFSEARCH.IO - Document Search Engine

Disease-modifying antirheumatic drug
Results: 192

#	Item
151	Azathioprine (Imuran) Azathioprine (Imuran) is a drug used to treat swelling and pain in arthritis. The most common diseases treated with Imuran are dermatomyositis, systemic lupus erythematosus and vasculitis. It belong Add to Reading List Source URL: www.rheumatology.org Language: English - Date: 2014-03-21 11:03:20 Autoimmune diseases Azathioprine Rheumatoid arthritis Rheumatology TNF inhibitor Disease-modifying antirheumatic drug Mercaptopurine Arthritis Dermatomyositis Medicine Health Anatomy
152	AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT: Ethical Use of Placebo in RA Clinical Trials Add to Reading List Source URL: www.rheumatology.org Language: English Pharmacology Science Bioethics Medical ethics Design of experiments Rheumatoid arthritis Placebo Disease-modifying antirheumatic drug Rheumatology Medicine Health Clinical research
153	SPECIAL AUTHORIZATION REQUEST RHEUMATOID ARTHRITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO C Add to Reading List Source URL: www.gov.pe.ca Language: English - Date: 2013-05-17 08:06:12 Immunology Rheumatoid arthritis Disease-modifying antirheumatic drug Leflunomide Rituximab Infliximab Hydroxychloroquine Abatacept TNF inhibitor Medicine Pharmacology Immunosuppressants
154	SPECIAL AUTHORIZATION REQUEST ANKYLOSING SPONDYLITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO Add to Reading List Source URL: www.gov.pe.ca Language: English - Date: 2011-05-12 11:07:44 Monoclonal antibodies Biology Centocor Rheumatology Infliximab Etanercept Adalimumab Disease-modifying antirheumatic drug Ankylosing spondylitis Medicine Pharmacology Immunosuppressants
155	American College of Rheumatology Five Things Physicians and Patients Should Question Don’t test ANA sub-serologies without a positive ANA and clinical suspicion of immune-mediated disease. Add to Reading List Source URL: www.rheumatology.org Language: English Rheumatology Autoimmune diseases Connective tissue diseases Aging-associated diseases Arthritis Rheumatoid arthritis Methotrexate Disease-modifying antirheumatic drug Systemic lupus erythematosus Health Medicine Anatomy
156	FDA Webinar Developing Drug Products for Rheumatoid Arthritis Draft Guidance July 25, 2013 Nikolay P. Nikolov, M.D. Add to Reading List Source URL: www.fda.gov Language: English Science Clinical research Bioethics Medical ethics Design of experiments Rheumatoid arthritis Disease-modifying antirheumatic drug Placebo Rheumatology Medicine Health Pharmacology
157	Health and Community Services The Newfoundland and Labrador Prescription Drug Program CRITERIA FOR THE COVERAGE OF SPECIAL AUTHORIZATION DRUGS Subject to revision Add to Reading List Source URL: www.health.gov.nl.ca Language: English - Date: 2014-05-30 09:13:21 Immunology Arthritis Autoimmune diseases Rheumatology Monoclonal antibodies Disease-modifying antirheumatic drug Rheumatoid arthritis Leflunomide Psoriatic arthritis Medicine Health Immunosuppressants
158	Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments Add to Reading List Source URL: www.gov.pe.ca Language: English - Date: 2013-09-18 09:47:25 Immunosuppressants Autoimmune diseases Connective tissue diseases Organochlorides Quinolines Disease-modifying antirheumatic drug Rheumatoid arthritis Leflunomide Tocilizumab Medicine Health Anatomy
159	Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments Add to Reading List Source URL: www.gov.pe.ca Language: English - Date: 2013-05-07 09:42:59 Immunosuppressants Autoimmune diseases Connective tissue diseases Organochlorides Quinolines Disease-modifying antirheumatic drug Rheumatoid arthritis Leflunomide Hydroxychloroquine Medicine Health Pharmacology
160	SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) For INITIATION of Coverage of Restricted Rheumatoid Arthritis Medications Pharmaceutical Services Department of Health an Add to Reading List Source URL: www.health.gov.nl.ca Language: English - Date: 2010-04-07 12:30:21 Medicine Monoclonal antibodies Arthritis Disease-modifying antirheumatic drug Rheumatoid arthritis Leflunomide Hydroxychloroquine Biologic Medical prescription Immunosuppressants Pharmacology Immunology